ScienceDex / Researcher record
Feng, Ph.d., Xue
- Carina Medical, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2023): $2M in linked award amounts across 1 award record · Award-linked rank #3764.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2023 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Feng, Ph.d., Xue as a PI. Multi-PI records show the full award amount for context.
- 75N91023C00051-0-9999-1N44Contact PIFY 2023 SBIR TOPIC 402 PHASE II. ENHANCE THE PERFORMANCE OF THE AI FOR LYMPH NODE DETECTION, SEGMENTATION AND MEASUREMENTS AND DEVELOP ADDITIONAL AI MODELS FOR MALIGNANCY CLASSIFICATION LEVERAGING MU$2Maward amount
Award organization
Organizations that administered FY2023 awards listing Feng, Ph.d., Xue as a PI.
FY2023 award administered by Carina Medical, LLC (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2023First NIH AwardCarina Medical, LLC
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #3764
- 2023Entered Top 25% NationallyRanked #3764